Patents expiring in 2030

US 7855221

Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Theravance, Inc. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855220

Bicyclic derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855233

Citrate salt of Rasagiline

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855291

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855191

Agent having a destructive effect on malignant tumors and method for the production thereof

C.Y.L. Pharmazeutika GmbH · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855276

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2010146171

NOUVELLE MÉTHODE D'ADMINISTRATION D'UN ALLERGÈNE DANS UNE IMMUNOTHÉRAPIE ALLERGÈNE-SPÉCIFIQUE

ALK ABELLO AS [DK] · Granted Thu Dec 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858795

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858797

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858749

Polymer-factor VIII moiety conjugates

Nektar Therapeutics · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858790

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858635

Spiro compounds as modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858592

Interfering RNAs against the promoter region of P53

The Board of Regents of the University of Texas System · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858123

Inorganic materials for hemostatic modulation and therapeutic wound healing

The Regents of the University of California · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858349

Anti-cancer compounds

The Regents of the University of Colorado · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858786

Pyrimidines and pyrazines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858657

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858633

Cycloalkyl substituted pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858792

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858605

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858583

Process for purifying glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2010331746

METHOD OF USING ENOXAPARIN FOR REDUCING THE RISK OF DEATH IN ACUTELY ILL MEDICAL PATIENTS

AVENTIS PHARMA SA [FR] · Granted Thu Dec 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2010331426

Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria

AIR LIQUIDE SANTE INT [FR] · Granted Thu Dec 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863047

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863041

Rabies virus vector systems and compositions and methods thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863262

Nitroxyl progenitors in the treatment of heart failure

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863275

Uses of tetrahydrobiopterin and derivatives thereof

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863282

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863286

Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863415

Amino acid and peptide conjugates of amiloride and methods of use thereof

The Regents of the University of California · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863421

Polymer-factor VIII moiety conjugates

Nektar Therapeutics · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863456

Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid

PTC THERAPEUTICS, INC. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862811

Protease inhibition for prevention or treatment of heart failure

The Regents of the University of Colorado · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862821

Recombinant vaccine against bluetongue virus

The Regents of the University of California · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862815

Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863309

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862605

Coated implantable medical device

Cook Regentec LLC · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863449

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863296

Selective serotonin receptor inverse agonists as therapeutics for disease

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863414

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862820

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)